![](http://investorshub.advfn.com/images/default_ih_profile2_4848.jpg?cb=0)
Thursday, December 30, 2021 9:37:32 AM
lenzilumab is by far the best drug not yet approved
Lenz might be the best Covid drug period. And it treats newly hospitalized patients. There are literally zero effective drugs currently authorized for newly hospitalized patients.
The ACTIV-5 trial will prove lenz's worth. The primary endpoint in the ACTIV-5 is for patients with CRP<150mg/L and <85yo. That group represented 336 of 479 patients in the LIVE-AIR trial. That group had 196% efficacy in the LIVE-AIR trial for a p value of 0.0003. That efficacy will be replicated in the ACTIV-5 because GM-CSF is the key to treating Covid.
https://www.bbc.com/news/health-56352128
Glidelogic Corp. Becomes TikTok Shop Partner, Opening a New Chapter in E-commerce Services • GDLG • Jul 5, 2024 7:09 AM
Freedom Holdings Corporate Update; Announces Management Has Signed Letter of Intent • FHLD • Jul 3, 2024 9:00 AM
EWRC's 21 Moves Gaming Studios Moves to SONY Pictures Studios and Green Lights Development of a Third Upcoming Game • EWRC • Jul 2, 2024 8:00 AM
BNCM and DELEX Healthcare Group Announce Strategic Merger to Drive Expansion and Growth • BNCM • Jul 2, 2024 7:19 AM
NUBURU Announces Upcoming TV Interview Featuring CEO Brian Knaley on Fox Business, Bloomberg TV, and Newsmax TV as Sponsored Programming • BURU • Jul 1, 2024 1:57 PM
Mass Megawatts Announces $220,500 Debt Cancellation Agreement to Improve Financing and Sales of a New Product to be Announced on July 11 • MMMW • Jun 28, 2024 7:30 AM